The medical landscape for glucose is evolving, and transdermal GLP-1 delivery systems represent a promising breakthrough. Unlike injections, this technique offers a less invasive way to administer GLP-1 therapies. These patches slowly release the drug through the surface offering a consistent amount of the beneficial agent, which can improve blood